← FDA Drug Approvals (Drugs@FDA)

SOLIFENACIN SUCCINATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: JUBILANT GENERICS · Approved 2024-10-02

Drug application

FDA Application #

ANDA205484

Application type

Abbreviated New Drug Application (Generic)

Brand name

SOLIFENACIN SUCCINATE

Generic name

Solifenacin Succinate

Active ingredients

SOLIFENACIN SUCCINATE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

JUBILANT GENERICS

First approval

2024-10-02

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown